Population pharmacokinetics and pharmacodynamic modeling of abacavir (1592U89) from a dose-ranging, double-blind, randomized monotherapy trial with human immunodeficiency virus-infected subjects.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples